A. and M. , , 2001.

R. J. Deberardinis and N. S. Chandel, Tumor hypoxia in cancer therapy, Fundamentals of cancer metabolism. Sci References 1. Brown, J.M, vol.435, pp.297-321, 2007.

M. Hirn, Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis. A clinical and experimental study. The European journal of surgery. Supplement. : = Acta chirurgica, Supplement, issue.570, pp.1-36, 1993.

E. J. Hall, The nitroimidazoles as radiosensitizers and cytotoxic agents

, The British journal of cancer. Supplement, vol.3, pp.120-123, 1978.

W. R. Wilson and M. P. Hay, Targeting hypoxia in cancer therapy, Nat. Rev. Cancer, vol.11, pp.393-410, 2011.

K. L. Bennewith and S. Dedhar, Targeting hypoxic tumour cells to overcome metastasis, BMC Cancer, vol.11, p.504, 2011.

C. T. Supuran, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat. Rev. Drug Discov, vol.7, pp.168-81, 2008.

P. Mcdonald,

J. Winum, C. T. Supuran, and S. Dedhar, Recent developments in targeting carbonic anhydrase IX for cancer therapeutics, Oncotarget, vol.3, pp.84-97, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00676865

D. Neri and C. T. Supuran, Interfering with pH regulation in tumours as a therapeutic strategy

, Nat. Rev. Drug Discov, vol.10, pp.767-77, 2011.

F. Pacchiano, F. Carta, P. C. Mcdonald, Y. Lou, D. Vullo et al.,

S. Dedhar and C. T. Supuran, Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis, J. Med. Chem, vol.54, pp.1896-902, 2011.

N. Touisni, A. Maresca, P. C. Mcdonald, Y. Lou, A. Scozzafava et al.,

J. Winum and C. T. Supuran, Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors, J. Med. Chem, vol.54, pp.8271-8278, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00676858

Y. Lou, P. C. Mcdonald, A. Oloumi, S. Chia, C. Ostlund et al.,

D. Waterhouse, M. Bally, C. Roskelley, C. M. Overall, A. Minchinton et al., Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors, Cancer Res, vol.71, pp.3364-76, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00676367

L. Dubois, S. Peeters, N. G. Lieuwes, N. Geusens, A. Thiry et al., Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation, Radiother. Oncol, vol.99, pp.424-455, 2011.

R. G. Gieling, M. Babur, L. Mamnani, N. Burrows, B. A. Telfer et al.,

J. Winum, A. Scozzafava, C. T. Supuran, and K. J. Williams, Antimetastatic effect of References

M. Nordsmark, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol.77, pp.18-24, 2005.

M. Hockel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer research, vol.56, pp.4509-4524, 1996.

J. W. Wojtkowiak, Drug resistance and cellular adaptation to tumor acidic pH microenvironment, Molecular pharmaceutics, vol.8, issue.6, pp.2032-2040, 2011.

J. S. Good and K. J. Harrington, The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology, Clinical oncology, vol.25, issue.10, pp.569-77, 2013.

L. J. Dubois, New ways to image and target tumour hypoxia and its molecular responses. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol.116, pp.352-359, 2015.

E. O. Pettersen, Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium, Journal of enzyme inhibition and medicinal chemistry, vol.30, issue.5, p.p, 2015.

P. Vaupel and A. Mayer, Hypoxia in cancer: significance and impact on clinical outcome, Cancer Metastasis Rev, vol.26, issue.2, pp.225-264, 2007.

P. Vaupel, M. Hockel, and A. Mayer, Detection and characterization of tumor hypoxia using pO2 histography, Antioxid Redox Signal, vol.9, issue.8, pp.1221-1256, 2007.

M. Nordsmark, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

, Radiother Oncol, vol.77, issue.1, pp.18-24, 2005.

A. M. Jubb, F. M. Buffa, and A. L. Harris, Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis, J Cell Mol Med, vol.14, issue.12, pp.18-29, 2010.

P. C. Mcdonald, Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia, Bioorg Med Chem Lett, vol.21, issue.1, pp.394-401, 2011.

I. M. Ernst, Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolin, Pharmacol Res, vol.70, issue.1, pp.155-62, 2013.

M. Bonnet, Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers, Bioorg Med Chem, vol.22, issue.7, pp.2123-2155, 2014.

S. Chopra, Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis, J Med Chem, vol.55, issue.13, pp.6047-60, 2012.

M. P. Hay, Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins, J Med Chem, vol.51, issue.21, pp.6853-65, 2008.

M. Y. Mboge, Structure activity study of carbonic anhydrase IX: Selective inhibition with ureido-substituted benzenesulfonamides, Eur J Med Chem, vol.132, pp.184-191, 2017.

R. G. Khalifah, The carbon dioxide hydration activity of carbonic anhydrase

I. , Stop-flow kinetic studies on the native human isoenzymes B and C, J Biol Chem, vol.246, issue.8, pp.2561-73, 1971.

S. Patiar and A. L. Harris, Role of hypoxia-inducible factor-1alpha as a cancer therapy target, Endocr Relat Cancer, vol.13, issue.1, pp.61-75, 2006.

C. J. Schofield and P. J. Ratcliffe, Oxygen sensing by HIF hydroxylases, Nature reviews. Molecular cell biology, vol.5, issue.5, pp.343-54, 2004.

E. Leochler, Environmental carcinogens and Mutagens. www.els.net (standard article), 2003.

P. H. Maxwell, The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis, Nature, vol.399, issue.6733, pp.271-276, 1999.

E. Berra, Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes

, O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm, EMBO Rep, vol.2, issue.7, pp.615-635, 2001.

M. Ivan, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, vol.292, issue.5516, pp.464-472, 2001.

K. Kondo, Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein, Cancer Cell, vol.1, issue.3, pp.237-283, 2002.

N. C. Denko and . Hypoxia, HIF1 and glucose metabolism in the solid tumour, Nature reviews. Cancer, vol.8, issue.9, pp.705-718, 2008.

B. G. Wouters and M. Koritzinsky, Hypoxia signalling through mTOR and the unfolded protein response in cancer, Nature reviews. Cancer, vol.8, issue.11, pp.851-64, 2008.

S. P. Pastorekova and J. , Cancer-Related Carbonic Anhydrase Isozymes

, Carbonic Anhydrase. Its Inhibitors and ActiVators

C. T. Supuran, A. Scozzafava, and . Conway, , pp.253-280, 2004.

C. T. Supuran, A. Scozzafava, and A. Casini, Carbonic anhydrase inhibitors. Medicinal research reviews, vol.23, pp.146-89, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00679259

I. Kurtz, Molecular mechanisms and regulation of urinary acidification

, Compr Physiol, vol.4, issue.4, pp.1737-74, 2014.

Y. Kato, Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. Front Oncol, Cancer Cell Int, vol.13, issue.1, pp.439-484, 2004.

A. Cecchi, Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors, J Med Chem, vol.48, issue.15, pp.4834-4875, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00127203

M. Rami, Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates, J Med Chem, vol.56, issue.21, pp.8512-8532, 2013.

C. T. Supuran, Carbonic anhydrase inhibitors: sulfonamides as antitumor agents, Bioorg Med Chem, vol.9, issue.3, pp.703-717, 2001.

S. Parkkila, Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro, Proc Natl Acad Sci, vol.97, issue.5, pp.2220-2224, 2000.

S. Pastorekova, Carbonic anhydrases: current state of the art, therapeutic applications and future prospects, J Enzyme Inhib Med Chem, vol.19, issue.3, pp.199-229, 2004.

W. A. Denny, Tumor-activated prodrugs-a new approach to cancer therapy

, Cancer Invest, vol.22, issue.4, pp.604-623, 2004.

M. P. Hay, DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine, J Med Chem, vol.47, issue.2, pp.475-88, 2004.

H. A. Seow, Bis(methylsulfonyl)-1-(2-chloroethyl)-2, vol.1

, Proc Natl Acad Sci U S A, vol.102, issue.26, pp.9282-9289, 2005.

M. Nomura, S. Shuto, and A. Matsuda, Synthesis of the cyclic and acyclic acetal derivatives of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, a potent antitumor nucleoside. Design of prodrugs to be selectively activated in tumor tissues via the bio-reduction-hydrolysis mechanism, Bioorg Med Chem, vol.11, issue.11, pp.2453-61, 2003.

R. M. Phillips, Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs, Biochem Pharmacol, vol.68, issue.11, pp.2107-2123, 2004.

G. De-simone, Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX, J Med Chem, vol.49, issue.18, pp.5544-51, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00127379

D. Ambrosio and K. , Carbonic anhydrase inhibitors: bioreductive nitrocontaining sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII, J Med Chem, vol.51, issue.11, pp.3230-3237, 2008.

J. H. Musser, Synthesis and antilipolytic activities of quinolyl carbanilates and related analogues, Journal of medicinal chemistry, vol.30, issue.1, pp.62-69, 1987.

R. G. Khalifah, The carbon dioxide hydration activity of carbonic anhydrase

I. , Stop-flow kinetic studies on the native human isoenzymes B and C. The Journal of biological chemistry, vol.246, pp.2561-73, 1971.

G. Tarzia, Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring, ChemMedChem, vol.1, issue.1, pp.130-139, 2006.

F. Meng, Molecular and cellular pharmacology of the hypoxiaactivated prodrug TH-302, Mol Cancer Ther, vol.11, issue.3, pp.740-51, 2012.

M. Bonnet, Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers, Bioorg Med Chem, vol.22, issue.7, pp.2123-2155, 2014.

G. E. Adams and I. J. Stratford, Hypoxia-mediated nitro-heterocyclic drugs in the radio-and chemotherapy of cancer. An overview, Biochem Pharmacol, vol.35, issue.1, pp.71-77, 1986.

T. W. Wong, G. F. Whitmore, and S. Gulyas, Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation

, Radiat Res, vol.75, issue.3, pp.541-55, 1978.

C. P. Guise, Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia, Chin J Cancer, vol.33, issue.2, pp.80-86, 2014.

A. N. Lukashev, Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954, Hum Gene Ther, vol.16, issue.12, pp.1473-83, 2005.

K. M. Johnson, Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine), J Org Chem, vol.79, issue.16, pp.7520-7551, 2014.

P. Ditte, Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors, Cancer research, vol.71, issue.24, pp.7558-67, 2011.

R. P. Hill, D. T. Marie-egyptienne, and D. W. Hedley, Cancer stem cells, hypoxia and metastasis, Semin Radiat Oncol, vol.19, issue.2, pp.106-117, 2009.

Q. Chang, Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer, Cancer Res, vol.71, issue.8, pp.3110-3130, 2011.
DOI : 10.1158/0008-5472.can-10-4049
URL : http://cancerres.aacrjournals.org/content/canres/71/8/3110.full.pdf

S. Pennacchietti, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, vol.3, issue.4, pp.347-61, 2003.
DOI : 10.1016/s1535-6108(03)00085-0
URL : https://doi.org/10.1016/s1535-6108(03)00085-0

G. L. Semenza, Hypoxia, clonal selection, and the role of HIF-1 in tumor progression, Crit Rev Biochem Mol Biol, vol.35, issue.2, pp.71-103, 2000.

M. Kioi, Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice, J Clin Invest, vol.120, issue.3, pp.694-705, 2010.

O. Warburg, On the origin of cancer cells, Science, vol.123, issue.3191, pp.309-323, 1956.

D. Neri and C. T. Supuran, Interfering with pH regulation in tumours as a therapeutic strategy, Nat Rev Drug Discov, vol.10, issue.10, pp.767-77, 2011.
DOI : 10.1038/nrd3554
URL : https://flore.unifi.it/bitstream/2158/776322/1/Nat_Rev_Drug_Disc.pdf

L. J. Dubois, New ways to image and target tumour hypoxia and its molecular responses, Radiother Oncol, vol.116, issue.3, pp.352-359, 2015.
DOI : 10.1016/j.radonc.2015.08.022
URL : https://doi.org/10.1016/j.radonc.2015.08.022

J. Pastorek and S. Pastorekova, Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use, Semin Cancer Biol, vol.31, pp.52-64, 2015.
DOI : 10.1016/j.semcancer.2014.08.002

C. T. Supuran, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat Rev Drug Discov, vol.7, issue.2, pp.168-81, 2008.
DOI : 10.1038/nrd2467

S. Pastorekova, Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts, Gastroenterology, vol.112, issue.2, pp.398-408, 1997.

C. C. Wykoff, Hypoxia-inducible expression of tumor-associated carbonic anhydrases, Cancer Res, vol.60, issue.24, pp.7075-83, 2000.
DOI : 10.1016/s0002-9440(10)64048-5
URL : http://europepmc.org/articles/pmc1850356?pdf=render

C. M. Douglas, Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1alpha and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy, Clin Oncol (R Coll Radiol), vol.25, issue.1, pp.59-65, 2013.

S. J. Kim, Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue, Jpn J Clin Oncol, vol.37, issue.11, pp.812-821, 2007.

E. Smeland, Prognostic impacts of hypoxic markers in soft tissue sarcoma, Sarcoma, p.541650, 2012.
DOI : 10.1155/2012/541650
URL : http://downloads.hindawi.com/journals/sarcoma/2012/541650.pdf

D. J. Stewart, Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer, J Thorac Oncol, vol.9, issue.5, pp.675-84, 2014.
DOI : 10.1097/jto.0000000000000148
URL : https://doi.org/10.1097/jto.0000000000000148

C. C. Wykoff, Expression of the hypoxia-inducible and tumorassociated carbonic anhydrases in ductal carcinoma in situ of the breast, Am J Pathol, vol.158, issue.3, pp.1011-1020, 2001.

S. J. Van-kuijk, Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. Front Oncol, vol.6, p.69, 2016.

Z. Zhao, Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature, PLoS One, vol.9, issue.11, p.114096, 2014.

S. Peridis, Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis, Eur Arch Otorhinolaryngol, vol.268, issue.5, pp.661-70, 2011.

E. Svastova, Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH, FEBS Lett, vol.577, issue.3, pp.439-484, 2004.

M. Bartosova, Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2

, J Pathol, vol.197, issue.3, pp.314-335, 2002.

P. Ebbesen, Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies, J Enzyme Inhib Med Chem, vol.24, issue.1, pp.1-39, 2009.

C. Lomelino and R. Mckenna, Carbonic anhydrase inhibitors: a review on the progress of patent literature, vol.26, pp.947-56, 2011.

S. M. Monti, C. T. Supuran, and G. D. Simone, Anticancer carbonic anhydrase inhibitors: a patent review, Expert Opin Ther Pat, issue.23, pp.737-786, 2008.

M. Rami, Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates, J Med Chem, vol.56, issue.21, pp.8512-8532, 2013.

P. Swietach, The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths, J Biol Chem, vol.284, issue.30, pp.20299-310, 2009.

P. Swietach, Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths, J Biol Chem, vol.283, issue.29, pp.20473-83, 2008.

L. H. Gray, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy, Br J Radiol, vol.26, issue.312, pp.638-686, 1953.

K. O. Alfarouk, Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp, Cancer Cell Int, vol.15, p.71, 2015.

K. L. Eales, K. E. Hollinshead, and D. A. Tennant, Hypoxia and metabolic adaptation of cancer cells. Oncogenesis, vol.5, p.190, 2016.

A. J. Primeau, The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors, Clin Cancer Res, vol.24, issue.11, pp.8782-8790, 2005.

G. L. Semenza, Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell, vol.5, pp.405-411, 2004.

M. Hirn, Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis. A clinical and experimental study, Eur J Surg Suppl, issue.570, pp.1-36, 1993.

E. J. Hall, The nitroimidazoles as radiosensitizers and cytotoxic agents

, Br J Cancer Suppl, vol.3, pp.120-123, 1978.

D. E. Adams, J. F. Wardman, P. Hypoxic, and C. Radiotherapy, The British journal of cancer. Supplement, vol.37, pp.1-132, 1978.

J. C. Asquith, Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiation research, vol.60, pp.108-126, 1974.

L. Dubois, Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs, Radiother Oncol, vol.108, issue.3, pp.523-531, 2013.

S. J. Van-kuijk, New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs, Eur J Med Chem, vol.127, pp.691-702, 2017.

J. Doyen, Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis. Front Oncol, vol.2, p.199, 2012.

A. Kulshrestha, Selective inhibition of tumor cell associated VacuolarATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells

, Mol Oncol, vol.10, issue.6, pp.789-805, 2016.

A. De-milito and S. Fais, Tumor acidity, chemoresistance and proton pump inhibitors, Future Oncol, vol.1, issue.6, pp.779-86, 2005.

C. Liao, Genomic screening in vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatin, Mol Pharmacol, vol.71, issue.2, pp.416-441, 2007.

W. R. Wilson and M. P. Hay, Targeting hypoxia in cancer therapy, Nat Rev Cancer, vol.11, issue.6, pp.393-410, 2011.

T. Thambi, Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery, Adv Healthc Mater, vol.3, issue.11, pp.1829-1867, 2014.

N. Baran and M. Konopleva, Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy, Clin Cancer Res, vol.23, issue.10, pp.2382-2390, 2017.

M. Bonnet, Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers, Bioorg Med Chem, vol.22, issue.7, pp.2123-2155, 2014.

W. A. Denny and W. R. Wilson, Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia, Expert Opin Investig Drugs, vol.9, issue.12, pp.2889-901, 2000.

K. O. Hicks, Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs, J Natl Cancer Inst, vol.98, issue.16, pp.1118-1146, 2006.

N. Kumar-parvathaneni, *. , R. Niemons, S. Bua, D. Suylen et al., Novel carbonic anhydrase IX targeting bio-reducible sulfonamides, Preparation

N. Kumar-parvathaneni, *. , R. Niemans, A. Yaromina, P. Lambin et al., Overview of Structure-Activity Relationship studies on nitroimidazoles as antimicrobial and radiosensitizing agents

N. Kumar-parvathaneni, *. , L. Dubois, A. Yaromina, S. Bua et al., Design and synthesis of Carbonic anhydrase IX inhibitors with different bio-reducible warheads, Submitted to J. Enzym. Inhb.Med.Chem

J. A. Simon, N. Van-kuijk, *. Kumar-parvathaneni, R. Niemans, W. Marike et al., Philippe Lambin. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs

, Eur. J. Med. Chem, vol.127, pp.691-702, 2017.

L. Dubois, R. Niemans, J. A. Simon, K. M. Van-kuijk, N. Panth et al., Marc Vooijs, Philippe Lambin. New ways to image and target tumour hypoxia and its molecular responses, vol.116, pp.352-357, 2015.

C. Ward, J. Meehan, P. Mullen, C. Supuran, J. Michael-dixon et al., Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models, Oncotarget, vol.6, pp.24856-24870, 2015.

L. Dubois, G. J. Sarah, . Peeters, J. A. Simon, A. Van-kuijk et al.,

, Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs, Radiother. Oncol, vol.108, pp.523-528, 2013.

M. Rami, L. Dubois, N. Kumar-parvathaneni, V. Alterio, S. M. Simon-van-kuijk et al.,

, Hypoxia-targeting Carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamide /sulfamide/sulfamte

, J. Med. Chem, vol.56, pp.8512-8520, 2013.

!. ,